The Blood-Brain Barrier and Whether Supplement Ingredients Reach the Brain

What the barrier is

A 2026 review describes the barrier as a highly organized interface made of cells lined up with very tight seals between them, supported by other brain cells. It protects the brain from circulating pathogens and toxins. [1] The vessel lining is continuous and has no gaps (it is described as nonfenestrated). [1]

How things get across

The same review says the barrier restricts approximately 98% of small-molecule drugs and nearly all large biomolecules from reaching the brain tissue. [1] That figure is about drug candidates, not about supplement ingredients, so it shows how selective the barrier is rather than how any one ingredient behaves.

There are several routes:

• Carriers for nutrients. The barrier's lining cells carry specific transporters for essential nutrients, including a glucose transporter and various amino acid transporters. [1]
• Fat-friendliness helps but is not enough. A 2025 review of natural compounds notes that lipophilicity (how fat-soluble a substance is) and passive transport are not the only determinants of crossing. [2]
• Pumps that push things back out. Efflux pumps actively pump lipophilic compounds back into the bloodstream, limiting brain accumulation of many therapeutic agents. [1]

What the sources say about specific ingredients

1. Does L-theanine reach the brain?

   Crossing noted; benefit claims limited by few rigorous human trials

   A 2025 review states it is well absorbed from the intestine and can cross the blood-brain barrier. [3] The same authors say the science does not yet match the hype for brain health and relaxation. [3]

2. Does supplemented creatine reach neurons in useful amounts?

   Insufficient; see where creatine for the brain is covered

   A 2026 commentary calls this a key uncertainty. [4] It concludes that creatine for cognition in older adults should be considered a hypothesis rather than an established clinical practice. [4]

3. How does choline get in?

   Preclinical; transport details are still being worked out. See choline

   A 2024 mouse and cell study identified a transporter protein for choline at the barrier. [5] Its final conclusion described that protein as a choline exporter at the barrier. [5]

4. Do plant-derived "nutraceuticals" help the barrier itself?

   Preclinical

   In preclinical studies modeling disease, nutraceuticals had beneficial effects on the barrier. [2] The reviewers add that the experimental model may fundamentally determine the outcome of a study. [2]

Why "it crosses" is not "it works"

Reaching the brain is one step. A trial still has to show a benefit on a meaningful outcome, in a defined group, compared with placebo. For that, see how brain supplement trials are designed. Findings in cells or animals do not transfer automatically to people, and findings in healthy young adults do not transfer to older adults or people with memory conditions. Proper evidence not found: we searched PubMed and Europe PMC for human studies that measured brain levels of common marketed nootropic ingredients and linked them to everyday memory outcomes, and did not find a source we could read that did so.

Related pages

See what nootropics are, L-theanine and the A to Z ingredient directory.